Home›Stock Screener›Lotus Eye Hospital

Lotus Eye Hospital Share Price Today | Stock Price & Lotus Eye Hospital Share Screener

LOTUSEYE Healthcare Services
Live Share Price NSE
₹101.12
▼ -1.13 (-1.11%)
2026-11-20 00:00:00
Live Share Price BSE
₹103.70
▲ 0.05 (0.05%)
2026-11-20 00:00:00

As of November 20, 2026, the live Lotus Eye Hospital share price (NSE: LOTUSEYE) is ₹101.12 on NSE and ₹103.70 on BSE, down 1.11% from the previous close, with shares trading between ₹100.22 and ₹103.00 in today's trading session, and a 52-week range of ₹98.22–₹141.38. Track Lotus Eye Hospital market worth to gauge the company's total market size. Use the Lotus Eye Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Lotus Eye Hospital opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Lotus Eye Hospital Market Cap ₹210.44 Cr.
LOTUSEYE P/E Ratio (TTM) 463.50
Lotus Eye Hospital P/B Ratio 3.62
EPS (TTM) ₹0.04
Dividend Yield 0.49%
Debt to Equity 0.16
LOTUSEYE 52 Week High ₹141.38
Lotus Eye Hospital 52 Week Low ₹98.22
Operating Margin 10.00%
Profit Margin -
LOTUSEYE Revenue (TTM) ₹63.00
EBITDA ₹8.00
Net Income -
Total Assets ₹83.00
Total Equity ₹60.00

Lotus Eye Hospital Share Price Chart

Track the current stock price of Lotus Eye Hospital with an interactive chart. Analyse LOTUSEYE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Lotus Eye Hospital stock quote in one place.

The quote of ₹101.12 sits between the 52-week low of ₹98.22 and the 52-week high of ₹141.38, and the latest session moved -1.11% from the previous close.

Lotus Eye Hospital Company Profile - Fundamental Screener

Screen Lotus Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LOTUSEYE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE947I01017.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE947I01017

Lotus Eye Hospital Balance Sheet Screener

Screen LOTUSEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹83, up from ₹70 in 2025.

Latest statistics put total assets at ₹83 and shareholder funds at ₹60, with a leverage ratio of 0.16.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 83 70 67 63 62 59 58 57 58 55
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 66 54 49 44 44 41 43 44 43 41

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 13 2 1 0 1 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 60 60 59 58 55 53 51 50 51 50
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 39 39 39 37 34 32 31 29 30 29

Lotus Eye Hospital Income Statement Screener - Profit & Revenue Analysis

Screen Lotus Eye Hospital income statement and profit fundamentals. Analyze LOTUSEYE quarterly results. Lotus Eye Hospital reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹63 and net profit was ₹0, equal to earnings per unit of ₹0.20, at an operating margin of 10%.

In that period expenses were ₹55, interest cost ₹2 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹55 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 63 55 51 50 48 40 33 42 39 39 35 32 30
Expenses 55 50 46 42 40 33 29 37 35 34 31 27 28

Operating Costs and Margins

EBITDA 8 5 5 8 9 7 4 5 4 5 4 5 3
Operating Profit % 10.00% 6.00% 7.00% 14.00% 16.00% 15.00% 11.00% 9.00% 8.00% 11.00% 10.00% 13.00% 7.00%
Depreciation 5 4 3 4 3 3 2 3 3 3 3 4 5
Interest 2 1 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 0 1 4 6 4 2 2 1 2 0 0 -2
Tax 0 0 1 1 2 1 0 0 0 0 0 0 0
Net Profit 0 0 1 3 4 3 2 1 1 2 0 0 -2
EPS 0.20 0.04 0.36 1.40 1.96 1.44 0.75 0.51 0.34 0.84 0.21 0.05 -0.95

Lotus Eye Hospital Cash Flow Screener - Liquidity Fundamentals

Screen LOTUSEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3, and net cash flow was an outflow of ₹2.

Over the same period, investing activities used ₹14 and financing activities provided ₹9.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 3 3 6 4 4 3 5 4 6 3
Investing Activities -14 -6 -5 -2 -4 1 -1 -4 -4 -1

Financing and Net Cash

Financing Activities 9 -2 -3 -2 -2 0 0 -1 -2 0
Net Cash Flow -2 -5 -2 1 -1 3 4 -1 0 2

Lotus Eye Hospital Shareholding Pattern Screener

See Lotus Eye Hospital shareholding pattern with promoter, FII, and DII holdings. Check Lotus Eye Hospital promoter holding and ownership changes for LOTUSEYE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 40.14%, foreign institutions 0.00%, domestic institutions 0.02% and the public 35.87%, spread across 9,572 shareholders.

The shareholder count was 9,572 in 2026-Sept, compared with 9,627 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 40.14% 40.14% 40.14% 40.67% 40.64% 40.39% 40.22% 40.14%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.01% 0.00% 0.01% 0.00% 0.00%
DII Holding 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.04% 0.04%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 35.87% 36.43% 36.73% 38.12% 38.70% 39.03% 40.95% 41.73%
Other Holding 23.98% 23.41% 23.11% 21.18% 20.64% 20.55% 18.79% 18.09%
Shareholder Count 9,572 9,627 9,939 10,240 10,777 11,121 11,508 11,734

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Lotus Eye Hospital. Lotus Eye Hospital dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.50 0.90%
2022-March ₹0.50 0.87%
2021-March ₹0.50 0.94%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.50 2.27%
2017-March ₹0.50 1.81%

Lotus Eye Hospital Stock Index Membership - Nifty & Sensex

See which indices include Lotus Eye Hospital stock. Check LOTUSEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Lotus Eye Hospital is not part of any tracked indices.
Only major market indices are tracked in our system.

Lotus Eye Hospital Market Events Screener - Corporate Actions

Get Lotus Eye Hospital corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Lotus Eye Hospital stock events that may affect LOTUSEYE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 11, 2026, with a record date of November 11, 2026.

It is followed by Annual General Meeting dated September 23, 2026 and Quarterly Result Announcement dated August 10, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-11 2026-11-11 Quarterly Result Announcement NA -3.85%
2026-09-23 2026-09-23 Annual General Meeting NA 6.36%
2026-08-10 2026-08-10 Quarterly Result Announcement NA -1.44%
2026-05-26 2026-05-26 Quarterly Result Announcement NA -0.86%
2026-02-11 2026-02-11 Quarterly Result Announcement NA -14.00%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.78%
2025-09-23 2025-09-23 Annual General Meeting NA 12.18%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.12%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -1.55%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 2.12%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -8.46%
2024-08-13 2024-08-13 Annual General Meeting NA 5.50%
2023-09-18 2023-09-18 Dividend ₹ 0.50 /share 11.71%
2022-09-08 2022-09-10 Dividend ₹ 0.50 /share 37.48%
2021-09-08 2021-09-11 Dividend ₹ 0.50 /share -10.42%

Lotus Eye Hospital Competitors Screener - Peer Stocks Comparison

Screen LOTUSEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,114 52.40 25,420 15.58% 2,003 64.36
Max Healthcare Institute 98,295 66.60 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 90,925 98.70 10,521 25.80% 917 58.01
Aster DM Quality Care 65,375 111.60 4,769 11.25% 427 61.53
Fortis Healthcare 60,638 54.40 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 38,733 44.30 7,996 43.43% 811 60.17
Global Health 38,545 63.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,582 56.90 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 32,061 155.60 3,931 28.16% 242 65.46
Syngene International 17,810 96.50 3,809 2.56% 317 66.04

Lotus Eye Hospital Company Announcements - News & Reports Screener

Screen LOTUSEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 18, 2026.

The next most recent announcements are dated November 18, 2026 and November 17, 2026.

Date Update Actions
2026-11-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-18 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-17 Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026. -
2026-11-17 Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026. -
2026-11-02 Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-10-30 Opening Of New Branch At Erode -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-25 Closure of Trading Window -
2026-09-24 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-23 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-09-01 29Th Annual General Meeting Of The Company - September 23 2026 -
2026-08-27 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-10 Results - Standalone Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-10 Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-01 Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-07-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹101.12, within a 52-week range of ₹98.22 to ₹141.38. The P/E ratio is 463.50 and the P/B ratio is 3.62, with earnings per unit of ₹0.04. Market capitalisation stands at ₹210.44 Cr and the dividend yield is 0.49%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 22, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.